JP2023534504A - ポリマー組み合わせ調製物を含む調製物及び組成物 - Google Patents

ポリマー組み合わせ調製物を含む調製物及び組成物 Download PDF

Info

Publication number
JP2023534504A
JP2023534504A JP2023503114A JP2023503114A JP2023534504A JP 2023534504 A JP2023534504 A JP 2023534504A JP 2023503114 A JP2023503114 A JP 2023503114A JP 2023503114 A JP2023503114 A JP 2023503114A JP 2023534504 A JP2023534504 A JP 2023534504A
Authority
JP
Japan
Prior art keywords
polymer
preparation
polymer combination
less
payload
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503114A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022016129A5 (https=
JP2023534504A5 (https=
Inventor
マイケル ソロモン ゴールドバーグ，
ポール アダム コノウィチ，
アイビー シャオユー チェン，
Original Assignee
サージ セラピューティクス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サージ セラピューティクス， インコーポレイテッド filed Critical サージ セラピューティクス， インコーポレイテッド
Publication of JP2023534504A publication Critical patent/JP2023534504A/ja
Publication of JPWO2022016129A5 publication Critical patent/JPWO2022016129A5/ja
Publication of JP2023534504A5 publication Critical patent/JP2023534504A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP2023503114A 2020-07-17 2021-07-17 ポリマー組み合わせ調製物を含む調製物及び組成物 Pending JP2023534504A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063053488P 2020-07-17 2020-07-17
US63/053,488 2020-07-17
US202063108861P 2020-11-02 2020-11-02
US63/108,861 2020-11-02
PCT/US2021/042110 WO2022016129A1 (en) 2020-07-17 2021-07-17 Preparations and compositions comprising polymer combination preparations

Publications (3)

Publication Number Publication Date
JP2023534504A true JP2023534504A (ja) 2023-08-09
JPWO2022016129A5 JPWO2022016129A5 (https=) 2024-07-17
JP2023534504A5 JP2023534504A5 (https=) 2024-07-17

Family

ID=79555039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503114A Pending JP2023534504A (ja) 2020-07-17 2021-07-17 ポリマー組み合わせ調製物を含む調製物及び組成物

Country Status (10)

Country Link
US (1) US20230293427A1 (https=)
EP (1) EP4181857A4 (https=)
JP (1) JP2023534504A (https=)
KR (1) KR20230041032A (https=)
CN (1) CN116133642A (https=)
AU (1) AU2021308083A1 (https=)
BR (1) BR112023000190A2 (https=)
CA (1) CA3187174A1 (https=)
IL (1) IL299806A (https=)
WO (1) WO2022016129A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021329884A1 (en) * 2020-08-17 2023-02-16 SURGE Therapeutics, Inc. Immune modulation of myeloid derived suppressive cell function for cancer treatment
CN114617903B (zh) * 2022-03-15 2024-05-24 中国人民解放军总医院第一医学中心 一种用于血浆冻干的组合物及其应用
KR20250030440A (ko) * 2022-04-29 2025-03-05 바이오데벡 인코포레이티드 생체적합성 접착제 물질 및 사용 방법
IT202300004218A1 (it) * 2023-03-07 2024-09-07 Delim Cosmetics & Pharma S R L Composizioni termoreversibili e mucoadesive
CN116554949A (zh) * 2023-05-16 2023-08-08 广州大学 一种润滑油添加剂及其制备方法
CN117619361A (zh) * 2023-12-09 2024-03-01 中北大学 改性高岭土/包覆型高铁酸钾复合材料及其制备方法
CN120324357B (zh) * 2025-06-03 2025-10-24 上海国创医药股份有限公司 一种普瑞巴林缓释组合物及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002516617A (ja) * 1995-06-16 2002-06-04 メドロジック グローバル コーポレイション 反応性ポリマー網状構造体及びその使用法
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
US20150366975A1 (en) * 2014-06-19 2015-12-24 Taipei Medical University Thermosensitive injectable hydrogel for drug delivery
WO2019092049A1 (en) * 2017-11-07 2019-05-16 Royal College Of Surgeons In Ireland A thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6385796A (en) * 1995-06-16 1997-01-15 Medlogic Global Corporation Responsive polymer networks and methods of their use
CA2401239A1 (en) * 2000-03-03 2001-09-13 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
US20060034889A1 (en) * 2004-08-16 2006-02-16 Macromed, Inc. Biodegradable diblock copolymers having reverse thermal gelation properties and methods of use thereof
CN101297973B (zh) * 2008-05-22 2010-06-09 武汉华纳生物工程有限公司 高生物粘附温敏水凝胶及其制备方法和用途
WO2010088924A1 (en) * 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
CN103055304A (zh) * 2013-01-19 2013-04-24 卓阳 一种治疗皮肤溃疡用复方温敏凝胶剂及其制备方法
CN104983722A (zh) * 2015-07-01 2015-10-21 苏州吉欧生物科技有限公司 一种皮肤祛疤修复喷膜剂的组合物及其制备方法
CN109820816B (zh) * 2019-02-18 2023-04-28 江苏拓弘生物科技有限公司 温度敏感性生物凝胶制剂及其应用
CN113766929A (zh) * 2019-05-02 2021-12-07 斯蒂米特公司 癌症治疗
KR102067490B1 (ko) * 2019-05-21 2020-01-20 주식회사 티젤바이오 서방성 약물전달용 온도상전이 나노 입자/하이드로젤 복합체
US12090205B2 (en) * 2019-10-28 2024-09-17 Rochal Technologies Llc Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002516617A (ja) * 1995-06-16 2002-06-04 メドロジック グローバル コーポレイション 反応性ポリマー網状構造体及びその使用法
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
US20150366975A1 (en) * 2014-06-19 2015-12-24 Taipei Medical University Thermosensitive injectable hydrogel for drug delivery
WO2019092049A1 (en) * 2017-11-07 2019-05-16 Royal College Of Surgeons In Ireland A thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers

Also Published As

Publication number Publication date
EP4181857A1 (en) 2023-05-24
WO2022016129A1 (en) 2022-01-20
CA3187174A1 (en) 2022-01-20
EP4181857A4 (en) 2024-08-14
IL299806A (en) 2023-03-01
BR112023000190A2 (pt) 2023-04-25
KR20230041032A (ko) 2023-03-23
CN116133642A (zh) 2023-05-16
US20230293427A1 (en) 2023-09-21
AU2021308083A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
JP2023534504A (ja) ポリマー組み合わせ調製物を含む調製物及び組成物
AU2024267047B2 (en) Degradable hyaluronic acid hydrogels
KR20230079036A (ko) 암 치료를 위한 골수 유래 억제 세포 기능의 면역 조절
JP2024151337A (ja) がんの処置
US20240082236A1 (en) Cancer therapy
KR20240107169A (ko) 핵산 조성물 및 이의 용도
JP2024542575A (ja) レシキモドの固体形態及びその製剤
HK40056414A (en) Degradable hyaluronic acid hydrogels

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250926

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260226